Paraneoplastic Leukocytosis: A Poor Prognostic Marker in Pancreatic Adenocarcinoma

Hyperleukocytosis is a rare form of paraneoplastic syndrome that has been reported in adenocarcinomas, particularly pancreatic cancer. We present an elderly man with chronic abdominal pain and weight loss for six months. On examination, he had diffuse tenderness and marked ascites. A workup with a C...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2020-07, Vol.12 (7)
Main Authors: Kabashneh, Sohaip, Ali, Hammad, Shanah, Layla, Alkofahi, Ala A, Alkassis, Samer
Format: Article
Language:English
Subjects:
Abdomen
Antibiotics
Ascites
Autoimmune diseases
Cancer
Case reports
Granulocytes
Growth factors
Hematology
Infections
Internal Medicine
Leukemia
Losses
Medical prognosis
Metastasis
Oncology
Pancreatic cancer
Patients
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c283t-b0c0c6bf86808d0c4952f19e0b5ced3aed88bffdc793e1af68473f4adb6cd85b3
cites cdi_FETCH-LOGICAL-c283t-b0c0c6bf86808d0c4952f19e0b5ced3aed88bffdc793e1af68473f4adb6cd85b3
container_end_page
container_issue 7
container_start_page
container_title Curēus (Palo Alto, CA)
container_volume 12
creator Kabashneh, Sohaip
Ali, Hammad
Shanah, Layla
Alkofahi, Ala A
Alkassis, Samer
description Hyperleukocytosis is a rare form of paraneoplastic syndrome that has been reported in adenocarcinomas, particularly pancreatic cancer. We present an elderly man with chronic abdominal pain and weight loss for six months. On examination, he had diffuse tenderness and marked ascites. A workup with a CT scan revealed a pancreatic mass, which was confirmed to be pancreatic adenocarcinoma on biopsy. His lab work showed a significant leukocytosis. An extensive infectious workup was negative. He was not on any medications known to cause a leukocytosis; therefore, his leukocytosis was attributed to his cancer. Unfortunately, he died just a few days later. This case highlights hyperleukocytosis as a paraneoplastic syndrome that is a poor prognostic sign, and can be used as a marker for disease progression.
doi_str_mv 10.7759/cureus.9013
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7405973</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2438856663</sourcerecordid><originalsourceid>FETCH-LOGICAL-c283t-b0c0c6bf86808d0c4952f19e0b5ced3aed88bffdc793e1af68473f4adb6cd85b3</originalsourceid><addsrcrecordid>eNpVkVtLAzEQhYMottQ--QcWfJStk81ukvVBKMUbVFxEn0M2l7q9JDXZFfrv7VoRfZphzplvBg5C5xgmjBXlleqC6eKkBEyO0DDDlKcc8_z4Tz9A4xiXAICBZcDgFA1Itl-GkgzRSyWDdMZv1zK2jUrmplt5tWt9bOJ1Mk0q70NSBb9w_lt_kmFlQtK4pJJOBSP74VQb55UMqnF-I8_QiZXraMY_dYTe7m5fZw_p_Pn-cTadpyrjpE1rUKBobTnlwDWovCwyi0sDdaGMJtJozmtrtWIlMVhaynNGbC51TZXmRU1G6ObA3Xb1xmhlXBvkWmxDs5FhJ7xsxH_FNe9i4T8Fy6EoGdkDLn4AwX90JrZi6bvg9j-LLCecF5TS3nV5cKngYwzG_l7AIPoMxCED0WdAvgAptXwz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2438856663</pqid></control><display><type>article</type><title>Paraneoplastic Leukocytosis: A Poor Prognostic Marker in Pancreatic Adenocarcinoma</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Kabashneh, Sohaip ; Ali, Hammad ; Shanah, Layla ; Alkofahi, Ala A ; Alkassis, Samer</creator><creatorcontrib>Kabashneh, Sohaip ; Ali, Hammad ; Shanah, Layla ; Alkofahi, Ala A ; Alkassis, Samer</creatorcontrib><description>Hyperleukocytosis is a rare form of paraneoplastic syndrome that has been reported in adenocarcinomas, particularly pancreatic cancer. We present an elderly man with chronic abdominal pain and weight loss for six months. On examination, he had diffuse tenderness and marked ascites. A workup with a CT scan revealed a pancreatic mass, which was confirmed to be pancreatic adenocarcinoma on biopsy. His lab work showed a significant leukocytosis. An extensive infectious workup was negative. He was not on any medications known to cause a leukocytosis; therefore, his leukocytosis was attributed to his cancer. Unfortunately, he died just a few days later. This case highlights hyperleukocytosis as a paraneoplastic syndrome that is a poor prognostic sign, and can be used as a marker for disease progression.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.9013</identifier><identifier>PMID: 32775093</identifier><language>eng</language><publisher>Palo Alto: Cureus Inc</publisher><subject>Abdomen ; Antibiotics ; Ascites ; Autoimmune diseases ; Cancer ; Case reports ; Granulocytes ; Growth factors ; Hematology ; Infections ; Internal Medicine ; Leukemia ; Losses ; Medical prognosis ; Metastasis ; Oncology ; Pancreatic cancer ; Patients ; Tumors</subject><ispartof>Curēus (Palo Alto, CA), 2020-07, Vol.12 (7)</ispartof><rights>Copyright © 2020, Kabashneh et al. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2020, Kabashneh et al. 2020 Kabashneh et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c283t-b0c0c6bf86808d0c4952f19e0b5ced3aed88bffdc793e1af68473f4adb6cd85b3</citedby><cites>FETCH-LOGICAL-c283t-b0c0c6bf86808d0c4952f19e0b5ced3aed88bffdc793e1af68473f4adb6cd85b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2438856663?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2438856663?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,38515,43894,44589,53790,53792,74183,74897</link.rule.ids></links><search><creatorcontrib>Kabashneh, Sohaip</creatorcontrib><creatorcontrib>Ali, Hammad</creatorcontrib><creatorcontrib>Shanah, Layla</creatorcontrib><creatorcontrib>Alkofahi, Ala A</creatorcontrib><creatorcontrib>Alkassis, Samer</creatorcontrib><title>Paraneoplastic Leukocytosis: A Poor Prognostic Marker in Pancreatic Adenocarcinoma</title><title>Curēus (Palo Alto, CA)</title><description>Hyperleukocytosis is a rare form of paraneoplastic syndrome that has been reported in adenocarcinomas, particularly pancreatic cancer. We present an elderly man with chronic abdominal pain and weight loss for six months. On examination, he had diffuse tenderness and marked ascites. A workup with a CT scan revealed a pancreatic mass, which was confirmed to be pancreatic adenocarcinoma on biopsy. His lab work showed a significant leukocytosis. An extensive infectious workup was negative. He was not on any medications known to cause a leukocytosis; therefore, his leukocytosis was attributed to his cancer. Unfortunately, he died just a few days later. This case highlights hyperleukocytosis as a paraneoplastic syndrome that is a poor prognostic sign, and can be used as a marker for disease progression.</description><subject>Abdomen</subject><subject>Antibiotics</subject><subject>Ascites</subject><subject>Autoimmune diseases</subject><subject>Cancer</subject><subject>Case reports</subject><subject>Granulocytes</subject><subject>Growth factors</subject><subject>Hematology</subject><subject>Infections</subject><subject>Internal Medicine</subject><subject>Leukemia</subject><subject>Losses</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Oncology</subject><subject>Pancreatic cancer</subject><subject>Patients</subject><subject>Tumors</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNpVkVtLAzEQhYMottQ--QcWfJStk81ukvVBKMUbVFxEn0M2l7q9JDXZFfrv7VoRfZphzplvBg5C5xgmjBXlleqC6eKkBEyO0DDDlKcc8_z4Tz9A4xiXAICBZcDgFA1Itl-GkgzRSyWDdMZv1zK2jUrmplt5tWt9bOJ1Mk0q70NSBb9w_lt_kmFlQtK4pJJOBSP74VQb55UMqnF-I8_QiZXraMY_dYTe7m5fZw_p_Pn-cTadpyrjpE1rUKBobTnlwDWovCwyi0sDdaGMJtJozmtrtWIlMVhaynNGbC51TZXmRU1G6ObA3Xb1xmhlXBvkWmxDs5FhJ7xsxH_FNe9i4T8Fy6EoGdkDLn4AwX90JrZi6bvg9j-LLCecF5TS3nV5cKngYwzG_l7AIPoMxCED0WdAvgAptXwz</recordid><startdate>20200705</startdate><enddate>20200705</enddate><creator>Kabashneh, Sohaip</creator><creator>Ali, Hammad</creator><creator>Shanah, Layla</creator><creator>Alkofahi, Ala A</creator><creator>Alkassis, Samer</creator><general>Cureus Inc</general><general>Cureus</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20200705</creationdate><title>Paraneoplastic Leukocytosis: A Poor Prognostic Marker in Pancreatic Adenocarcinoma</title><author>Kabashneh, Sohaip ; Ali, Hammad ; Shanah, Layla ; Alkofahi, Ala A ; Alkassis, Samer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c283t-b0c0c6bf86808d0c4952f19e0b5ced3aed88bffdc793e1af68473f4adb6cd85b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abdomen</topic><topic>Antibiotics</topic><topic>Ascites</topic><topic>Autoimmune diseases</topic><topic>Cancer</topic><topic>Case reports</topic><topic>Granulocytes</topic><topic>Growth factors</topic><topic>Hematology</topic><topic>Infections</topic><topic>Internal Medicine</topic><topic>Leukemia</topic><topic>Losses</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Oncology</topic><topic>Pancreatic cancer</topic><topic>Patients</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kabashneh, Sohaip</creatorcontrib><creatorcontrib>Ali, Hammad</creatorcontrib><creatorcontrib>Shanah, Layla</creatorcontrib><creatorcontrib>Alkofahi, Ala A</creatorcontrib><creatorcontrib>Alkassis, Samer</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kabashneh, Sohaip</au><au>Ali, Hammad</au><au>Shanah, Layla</au><au>Alkofahi, Ala A</au><au>Alkassis, Samer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Paraneoplastic Leukocytosis: A Poor Prognostic Marker in Pancreatic Adenocarcinoma</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><date>2020-07-05</date><risdate>2020</risdate><volume>12</volume><issue>7</issue><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Hyperleukocytosis is a rare form of paraneoplastic syndrome that has been reported in adenocarcinomas, particularly pancreatic cancer. We present an elderly man with chronic abdominal pain and weight loss for six months. On examination, he had diffuse tenderness and marked ascites. A workup with a CT scan revealed a pancreatic mass, which was confirmed to be pancreatic adenocarcinoma on biopsy. His lab work showed a significant leukocytosis. An extensive infectious workup was negative. He was not on any medications known to cause a leukocytosis; therefore, his leukocytosis was attributed to his cancer. Unfortunately, he died just a few days later. This case highlights hyperleukocytosis as a paraneoplastic syndrome that is a poor prognostic sign, and can be used as a marker for disease progression.</abstract><cop>Palo Alto</cop><pub>Cureus Inc</pub><pmid>32775093</pmid><doi>10.7759/cureus.9013</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2020-07, Vol.12 (7)
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7405973
source Publicly Available Content (ProQuest); PubMed Central; Coronavirus Research Database
subjects Abdomen
Antibiotics
Ascites
Autoimmune diseases
Cancer
Case reports
Granulocytes
Growth factors
Hematology
Infections
Internal Medicine
Leukemia
Losses
Medical prognosis
Metastasis
Oncology
Pancreatic cancer
Patients
Tumors
title Paraneoplastic Leukocytosis: A Poor Prognostic Marker in Pancreatic Adenocarcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T03%3A53%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Paraneoplastic%20Leukocytosis:%20A%20Poor%20Prognostic%20Marker%20in%20Pancreatic%20Adenocarcinoma&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Kabashneh,%20Sohaip&rft.date=2020-07-05&rft.volume=12&rft.issue=7&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.9013&rft_dat=%3Cproquest_pubme%3E2438856663%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c283t-b0c0c6bf86808d0c4952f19e0b5ced3aed88bffdc793e1af68473f4adb6cd85b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2438856663&rft_id=info:pmid/32775093&rfr_iscdi=true